Clinical Trial Update: Therapeutic Strategy Guided by PET-TDM for Patients With Seminoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating PET-TDM-guided therapy for seminoma; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Seminoma

Snippet

Sponsor: Gustave Roussy, Cancer Campus, Grand Paris | Conditions: Seminoma | Phase 2 | Status: RECRUITING